Biolife Solutions Income Statement (2010-2026) | BLFS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	31.20M	33.80M	37.30M	36.22M	40.53M	40.75M	-41.26M	37.70M	29.24M	23.57M	-13.98M	18.43M	19.71M	21.39M	15.11M	22.05M	25.42M	28.07M	18.79M	27.50M
Cost of Revenue (Quarter)	1.43M	21.67M	26.40M	1.92M	1.67M	1.88M	-4.45M	3.89M	1.70M	1.07M	15.07M		5.94M	0.01M	21.79M	7.25M	0.01M	0.01M	31.27M	10.00M
Gross Profit (Quarter)	29.78M	12.13M	10.91M	34.30M	38.87M	38.87M	-36.81M	33.81M	27.54M	22.50M	-29.05M	18.43M	13.78M	21.38M	-6.68M	14.80M	25.41M	28.06M	-12.48M	17.50M
Operating items
Amortization - Intangibles (Quarter)	1.90M	2.52M	2.86M	2.86M	2.86M	2.50M	-4.21M	1.46M	1.41M	1.31M	-3.10M	0.69M	0.68M	0.68M	-1.84M	0.07M	0.70M	0.70M	-1.84M	0.09M
Research & Development (Quarter)	3.14M	4.07M	4.78M	4.89M	3.43M	5.28M	-6.93M	4.15M	3.83M	3.74M	-7.22M	2.08M	2.48M	1.89M	1.57M	1.44M	2.73M	2.53M	2.22M	2.53M
Selling, General & Administrative (Quarter)	7.15M	10.08M	11.61M	11.53M	11.65M	11.92M	-1.84M	14.84M	13.54M	10.81M	5.22M	10.40M	9.32M	9.33M	11.59M	11.35M	11.40M	12.07M	10.55M	12.21M
Restructuring Costs (Quarter)	0.27M	0.34M	0.02M	0.01M	0.01M	0.00M						0.24M
Other Operating Expenses (Quarter)	25.20M	30.47M	39.36M	27.75M	102.01M	35.29M	-122.83M	32.31M	22.49M	24.50M	-56.21M	9.02M	9.22M	10.59M	-23.14M	2.51M	27.94M	13.55M	-29.43M	2.73M
Operating Expenses (Quarter)	35.76M	44.96M	55.77M	44.19M	117.10M	52.49M	-131.61M	51.31M	39.87M	39.05M	-58.20M	21.73M	21.02M	21.81M	-9.98M	15.30M	42.06M	28.16M	-16.66M	17.47M
Operating Income (Quarter)	-4.55M	-11.16M	-18.46M	-7.97M	-76.56M	-11.74M	90.35M	-13.61M	-10.63M	-15.47M	17.53M	-3.29M	-1.31M	-0.42M	0.54M	-0.50M	-16.64M	-0.09M	1.35M	0.03M
EBIT (Quarter)	-4.55M	-11.16M	-18.46M	-7.97M	-76.56M	-11.74M	90.35M	-13.61M	-10.63M	-15.47M	17.53M	-3.29M	-1.31M	-0.42M	0.54M	-0.50M	-16.64M	-0.09M	1.35M	0.03M
Non-operating items
Non Operating Investment Income (Quarter)				-0.18M		0.70M		-0.41M					-4.07M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)		-0.01M	0.30M	0.13M	-0.02M	0.14M	0.39M	0.39M	0.38M	0.23M	0.27M	0.25M	0.15M	0.10M	-0.00M	0.10M	0.25M	0.28M	1.18M	0.18M
Non Operating Income (Quarter)	-0.12M	-0.19M	6.46M	-0.05M	-0.05M	0.82M	-0.03M	-0.41M	-0.39M	-0.21M	0.08M	-0.14M	-4.25M	-0.23M	-3.65M	0.68M	0.93M	0.51M	2.02M	1.22M
Net income details
EBT (Quarter)	-4.68M	-4.91M	-18.32M	-8.02M	-76.62M	-10.92M	90.70M	-13.62M	-5.52M	-15.69M	17.61M	-3.18M	-5.56M	-0.55M	0.47M	0.28M	-15.71M	0.70M	3.36M	1.25M
Tax Provisions (Quarter)	-12.55M	-4.99M	-2.58M	-0.60M	-3.74M	-0.60M	-0.30M	0.09M	0.00M	0.12M	-0.27M	0.02M	0.00M	-0.08M	0.02M	0.01M	0.13M	0.08M	-0.15M	0.06M
Profit After Tax (Quarter)	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	-49.19M	-13.71M	-10.20M	-29.13M	40.89M	-10.22M	-5.56M	-0.47M	0.45M	0.27M	-15.84M	0.62M	11.07M	1.19M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-5.52M	-15.80M	17.89M	-3.20M	-5.56M	-0.47M	0.45M	0.27M	-15.84M	0.62M	3.51M	1.19M
Income from Discontinued Operations (Quarter)									0.00M		-0.24M	0.11M		0.05M	-0.30M
Consolidated Net Income (Quarter)	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-4.68M	-13.33M	-32.61M	-6.91M	-15.16M	-1.18M	11.98M	-0.72M			7.54M
Income towards Parent Company (Quarter)	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	91.00M	-13.71M	-4.68M	-13.33M	-32.61M	-6.91M	-15.16M	-1.18M	11.98M	-0.72M			7.54M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	7.88M	0.08M	-15.74M	-7.42M	-72.88M	-10.32M	-49.19M	-13.71M	-5.52M	-29.13M	-13.38M	-10.22M	-20.72M	-1.70M	11.98M	-0.45M	-15.84M		7.54M
Additional items
EPS (Basic) (Quarter)	0.21	0.00	-0.41	-0.18	-1.72	-0.24	-1.16	-0.32	-0.13	-0.67	-0.31	-0.22	-0.45	-0.04	0.26	-0.01	-0.33		0.16
EPS (Diluted) (Quarter)	0.19	0.00	-0.41	-0.19	-1.72	-0.24	-1.16	-0.32	-0.13	-0.67	-0.31	-0.22	-0.45	-0.04	0.26	-0.01	-0.33		0.15
Shares Outstanding (Quarter)	38.07M	40.91M	38.50M	42.01M	42.46M	42.65M	42.48M	43.03M	43.44M	43.57M	43.72M	45.43M	46.00M	46.18M	46.07M	47.13M	47.80M	47.93M	47.75M	48.46M
Shares Outstanding (Diluted) (Quarter)	40.39M	43.30M	38.50M	38.50M	42.46M	42.65M	42.48M	43.03M	43.44M	43.57M	43.72M	45.43M	46.00M	46.18M	46.07M	47.13M	47.80M	48.72M	48.65M	49.25M
Shares Outstanding (Entity) (Quarter)	40.56M	41.44M	41.82M	42.33M	42.54M	42.71M	42.83M	43.29M	43.44M	43.83M	45.17M	45.69M	46.10M	46.23M	46.91M	47.55M	47.85M	47.97M	48.20M	48.83M
EBITDA (Quarter)	-4.55M	-11.16M	-18.46M	-7.97M	-76.56M	-11.74M	90.35M	-13.61M	-10.63M	-15.47M	17.53M	-3.29M	-1.31M	-0.42M	0.54M	-0.50M	-16.64M	-0.09M	1.35M	0.03M
Interest Expenses (Quarter)	30.00M	9.73M	0.45M	10.20M	21.60M	20.50M	0.36M	40.10M	44.10M	48.20M	0.53M	54.70M	3.50M	3.60M	0.37M	2.82M	16.37M	15.59M	0.12M	14.38M
Tax Rate (Quarter)	268.43%	101.61%	14.07%	7.47%	4.88%	5.49%	-0.33%	-0.68%	-0.04%	-0.73%	-1.55%	-0.53%	-0.02%	14.52%	5.12%	4.91%	-0.80%	11.66%	-4.49%	4.97%

Research Tools

Developers

Biolife Solutions Income Statement (2010-2026) | BLFS

Research Tools

Developers

Biolife Solutions Income Statement (2010-2026) | BLFS

Create an account

Sign In

Reset Password